OMERS ADMINISTRATION Corp grew its holdings in AMETEK, Inc. (NYSE:AME - Free Report) by 1.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 90,128 shares of the technology company's stock after buying an additional 1,632 shares during the quarter. OMERS ADMINISTRATION Corp's holdings in AMETEK were worth $16,246,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AME. National Bank of Canada FI boosted its stake in AMETEK by 17.4% during the 4th quarter. National Bank of Canada FI now owns 142,093 shares of the technology company's stock worth $25,616,000 after acquiring an additional 21,009 shares during the last quarter. Czech National Bank grew its holdings in shares of AMETEK by 6.3% during the fourth quarter. Czech National Bank now owns 50,153 shares of the technology company's stock worth $9,041,000 after buying an additional 2,987 shares in the last quarter. Assenagon Asset Management S.A. raised its position in AMETEK by 434.5% in the 4th quarter. Assenagon Asset Management S.A. now owns 541,517 shares of the technology company's stock valued at $97,614,000 after buying an additional 440,197 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in AMETEK by 16.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 88,898 shares of the technology company's stock worth $16,025,000 after buying an additional 12,584 shares in the last quarter. Finally, Fox Run Management L.L.C. raised its holdings in AMETEK by 74.1% during the fourth quarter. Fox Run Management L.L.C. now owns 8,418 shares of the technology company's stock worth $1,517,000 after acquiring an additional 3,584 shares in the last quarter. Institutional investors own 87.43% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on AME. Morgan Stanley began coverage on shares of AMETEK in a research report on Monday, April 14th. They issued an "equal weight" rating and a $170.00 target price for the company. Robert W. Baird decreased their price target on AMETEK from $197.00 to $190.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 7th. BNP Paribas upgraded shares of AMETEK from a "neutral" rating to an "outperform" rating and set a $210.00 price target on the stock in a report on Thursday, January 16th. Truist Financial upped their target price on AMETEK from $196.00 to $200.00 and gave the company a "buy" rating in a report on Monday, May 5th. Finally, StockNews.com raised AMETEK from a "hold" rating to a "buy" rating in a research note on Monday. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, AMETEK currently has an average rating of "Moderate Buy" and a consensus price target of $196.90.
Get Our Latest Stock Analysis on AME
Insider Buying and Selling at AMETEK
In other news, Director Thomas A. Amato sold 710 shares of the stock in a transaction that occurred on Thursday, March 27th. The stock was sold at an average price of $176.64, for a total transaction of $125,414.40. Following the sale, the director now directly owns 10,560 shares in the company, valued at approximately $1,865,318.40. This represents a 6.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Steven W. Kohlhagen sold 1,320 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $189.41, for a total transaction of $250,021.20. Following the transaction, the director now directly owns 22,029 shares in the company, valued at approximately $4,172,512.89. The trade was a 5.65% decrease in their position. The disclosure for this sale can be found here. 0.57% of the stock is owned by corporate insiders.
AMETEK Stock Performance
Shares of AME stock traded up $2.60 during mid-day trading on Friday, reaching $182.81. The stock had a trading volume of 1,167,568 shares, compared to its average volume of 1,296,916. The company has a current ratio of 1.24, a quick ratio of 0.75 and a debt-to-equity ratio of 0.15. AMETEK, Inc. has a 1-year low of $145.02 and a 1-year high of $198.33. The firm has a market cap of $42.21 billion, a price-to-earnings ratio of 30.83, a PEG ratio of 2.73 and a beta of 1.12. The business's fifty day moving average is $168.25 and its 200-day moving average is $179.74.
AMETEK (NYSE:AME - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The technology company reported $1.75 earnings per share for the quarter, topping analysts' consensus estimates of $1.69 by $0.06. The company had revenue of $1.73 billion during the quarter, compared to analysts' expectations of $1.74 billion. AMETEK had a return on equity of 16.94% and a net margin of 19.83%. AMETEK's quarterly revenue was down .2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.64 EPS. On average, research analysts forecast that AMETEK, Inc. will post 7.15 earnings per share for the current year.
AMETEK Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Friday, June 13th will be paid a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 0.68%. The ex-dividend date of this dividend is Friday, June 13th. AMETEK's dividend payout ratio (DPR) is 20.29%.
AMETEK announced that its board has initiated a stock repurchase program on Friday, February 7th that authorizes the company to buyback $1.25 billion in shares. This buyback authorization authorizes the technology company to buy up to 2.9% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board believes its stock is undervalued.
AMETEK Company Profile
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Recommended Stories

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report